Immune-Mediated Hemolytic Anemia (Canine) — NAVLE Prep

Quick anchor

Trigger

Regenerative anemia + spherocytes / agglutination

First step

Stabilize oxygen delivery; transfuse if needed

Treat

Immunosuppression + thrombosis awareness

Trap

Do not confuse with blood loss anemia

Exam core — read this first

Classic pattern → regenerative anemia, spherocytes, autoagglutination, icterus

If unstable → support oxygen delivery and transfuse as needed

Core therapy → immunosuppression, usually prednisone-based

Do not forget → thromboembolism risk is part of the disease

Pattern recognition

Core pattern

Pale or icteric dogRegenerative anemiaSpherocytes / agglutination

Supporting clues

TachycardiaPigmenturia possibleHyperbilirubinemiaWeakness / collapseFever possible

NAVLE trigger: If the anemia is regenerative and hemolytic, think IMHA before defaulting to hemorrhage.

Decision core — what NAVLE actually asks

Critically anemic patient

→ Stabilize oxygen delivery and transfuse while you continue the workup

Smear supports immune-mediated hemolysis

→ Start immunosuppressive therapy after appropriate sampling

Ongoing management

→ Monitor response and remember thrombosis prevention thinking

Key interpretation

PCV / HCT

↓ Low

Often severe

Reticulocytes

↑ Regenerative

Unless very early

Smear

Spherocytes

High-yield clue

Agglutination

Positive

Supports immune-mediated process

Bilirubin

↑ High

Common with hemolysis

Platelets

Check carefully

Evan's syndrome question may appear

⚠ A positive saline agglutination test and spherocytes are more board-useful than waiting for a Coombs result in the crashing patient.

Treatment

Stabilize

Packed RBC transfusion if oxygen delivery is inadequate

Do not let perfection delay rescue of the severely anemic patient.

Core Rx

Prednisone-based immunosuppression

Often the first board answer unless the question clearly asks about refractory disease.

Also

Think thromboprophylaxis and search for secondary triggers

The exam increasingly expects you to respect thromboembolism risk.

NAVLE traps — where students lose marks

Do not confuse hemolysis with simple blood loss

Spherocytes, icterus, and agglutination point you toward hemolysis.

Do not wait too long to transfuse the crashing dog

Stabilization matters before academic completeness.

Coombs is not the only way to support diagnosis

Boards often want smear plus saline agglutination reasoning.

Thrombosis risk is part of the disease

IMHA is not just an anemia question.

Differentials — how to separate these on NAVLE

Fast separator: IMHA is regenerative, hemolytic anemia. The board contrasts it with blood loss, toxin-mediated hemolysis, and infectious causes.

Disease	Regenerative?	Hemolysis clues	Key separator
IMHA	Usually yes	Spherocytes / agglutination	Icterus and immune-mediated pattern
Acute blood loss	Yes after delay	No	External / internal hemorrhage clues
Zinc or oxidative hemolysis	Yes	Hemolysis yes	History / Heinz body pattern
Babesia / infectious hemolysis	Yes	Hemolysis yes	Travel / tick / organism clues
Nonregenerative anemia	No	No	Marrow or chronic disease logic

30-second revision

Classic patternRegenerative anemia + spherocytes / agglutination

Physical cluesPale, weak, tachycardic, maybe icteric

StabilizeTransfuse if oxygen delivery is poor

Core therapyPrednisone-based immunosuppression

Useful evidenceSpherocytes + saline agglutination

Think broaderSearch for secondary trigger

Critical trapRemember thrombosis risk

Practice questions

Pre-built NAVLE-style · Immune-mediated hemolytic anemia

0 / 0

Q1Recognition

A dog has weakness, tachycardia, icterus, regenerative anemia, and marked spherocytosis on blood smear. Which diagnosis is most likely?

Q2Stabilization

A dog with suspected IMHA is collapsing with a critically low PCV. What is the best immediate management principle?

Q3Evidence

Which finding most strongly supports immune-mediated hemolysis over simple blood loss anemia?

Q4Treatment

Which therapy is most central to initial treatment of primary canine IMHA?

Q5Trap question

Why is canine IMHA considered especially high-risk even after initial stabilization?